Narwal, Rajesh
AstraZeneca (United Kingdom)
2 papers on CoChat
Most cited papers
- Verified
Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study
Antonia, S., Goldberg, S. B., Balmanoukian, A., Chaft, J. E., Sanborn, R. E., Gupta, A., Narwal, R., Steele, K., Gu, Y., Karakunnel, J. J., et al. (2016) · The Lancet Oncology
Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations
Cited by 602
- Verified
Detecting bliss synergy in in vivo combination studies with a tumor kinetic model
Zhao, W., Vicini, P., Novick, S., Anderton, J., Davies, G., DAngelo, G., O'Day, T., Yu, B., Harper, J., Narwal, R., et al. (2019) · Pharmaceutical Statistics
Mathematical Biology Tumor GrowthStatistical Methods in Clinical Trials
Cited by 4
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free